The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- NYSC urges employers to prioritize corps members’ welfare
- Tinubu urges NANS to foster constructive criticism for education growth
- Residents urge action on poor sanitation at Ikorodu garage
- Sony’s move to digital games sparks gaming community concerns
- Tinubu promises clean water for all FCT area councils
- Business confidence weakens in June as rising costs pressure Nigerian firms – CBN survey
- Tinubu’s state police bill gains momentum as Reps adopt executive proposal
- OMO maturities to inject N3.12tr into financial system this week – FMDA
